The agreement for Novartis to buy Alcon from Nestlé has completed its first step, with Novartis paying about $10.4 billion for 74 million shares of Alcon, or just under 25 percent of the company's common stock. At this point, Nestlé retains majority ownership with about 52 percent. However, Novartis has ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.